Optical diagnosticsspectropathology for the next generation This latest Optical Diagnosis themed issue of Analyst, guest-edited by Prof. Malgorzata Baranska, Jagiellonian University, Krakow, Poland, and Prof. Hugh J. Byrne, Dublin Institute of Technology, Ireland, is drawn from the participants and proceedings of the International conference, SPEC 2014: Shedding New Light on Disease, which was held on the 17th-22nd August 2014 in Krakow, Poland. The conference was co-chaired by Prof. Baranska, Prof. Byrne and Prof. Anna Sulkowska, Medical University of Silesia, Katowice, Poland.
The event was the eighth in the series of biennial conferences, the aim of which is to bring together clinicians and scientists who have joined forces in the quest for novel biomedical applications of infrared and Raman spectroscopy to improve patient care. Recent advances in the biological sciences and medicine have led to an increasing demand for real-time and minimally invasive chemical and structural information on biological materials. Due to its unique fingerprinting capability, vibrational spectroscopy plays a significant role in histopathology, cytology, biopsy targeting, surgical targets, treatment-monitoring and drug studies.
The conference aimed to highlight further advances in state of the art and emerging biomedical applications of vibrational spectroscopy, while reviewing the challenges in the context of other emerging technologies. The programme was constructed in an attempt to prioritise real-world applications from the outset, systematically progressing from research towards in-vivo, ex-vivo and in-vitro applications, as well as emerging technologies and data processing.
A feature of the conference was the daily discussion sessions which were aimed at a critical assessment of the routes towards the further development of clinical applications, and were moderated by members of the SPEC International Advisory Board. The deliberations are summarised in the second editorial 'Spectropathology for the next generation: Quo vadis? ' (Byrne et al., c4an02036g) , under the headings of (i) Translational research into in-vivo clinical applications, (ii) Ex-vivo tissue biopsies, body fluids and cytological samples for diagnostics and disease studies, and (iii) In-vitro cell culture and 3D models for research and medical applications. A number of critical concerns are highlighted under the respective headings, including (i) the need for the engagement with the clinical community and adherence to clinical standards in terms of statistical relevance, (ii) standardisation of protocols for sample preparation, presentation and measurement and data processing, and (iii) continued development of instrumentation and models to explore the limitations of the techniques.
The scope of the conference and the contents of this themed issue are indicative of the progress in the understanding of the complexity of spectroscopic characterisation of biological materials, and data preprocessing and postprocessing methods can increasingly be applied with confidence to give true biochemical representations of tissue, cells and bodily fluids. The issue contains a total of 51 contributed communications and articles, drawing from research activities across the globe, including Australia, India, Japan, US and across Europe with a notably strong representation from the host country, Poland.
The increased development of fibre probes shows great promise for in-vivo diagnosis and intra-operative applications, and although Raman probesoperating at visible or near-infrared wavelengthsare relatively well established, probes for FTIR spectroscopy are less so. The study by Padalkar and Pleshko (c4an01987c) details the development of such probes for the in-vivo analysis of cartilage.
For clinical applications, the research field remains dominated by ex-vivo applications of tissue, cells and biofluids. Spectrohistopathological studies using either FTIR or Raman profiling range from analysis of cancer markers in adrenal glands (Dudala et al., Cytological studies, using FTIR and FTIR-ATR spectroscopy also feature strongly, in, for example, the study by Diem et al. Spectroscopic techniques remain a powerful tool for basic research and may find applications in vitro for toxicology and drug screening, as exemplified by the study of cellular uptake of doxorubicin by Chlopicki, Baranska and coworkers (c4an01882f ), and the study of the biocompatibility of nanocomposites by Wesełucha-Birczyńska et al. Although the proof of concept of a range of potential clinical applications of vibrational spectroscopy has been well demonstrated, there remains the need for standardisation of measurement protocols and data processing, as highlighted in the discussion editorial (Byrne et al., c4an02036g) Emerging technologies continue to push the performances in terms of spatial resolution (Gough et al., c4an01982b), sampling depth (Ariese et al., c4an01889c) and the emergence of quantum cascade lasers as IR sources promises increased scanning speeds for large area spectral mapping (Kröger-Lui et al., c4an02001d) . Meanwhile, Czepiel, Wesełucha-Birczyńska and co-workers (c4an01947d) give glimpses into applications beyond human pathologies.
The field of clinical applications of vibrational spectroscopy continues to engage a broad interdisciplinary research community across the world, including spectroscopists, chemists, biochemists etc. The field is furthermore becoming increasingly intersectoral, as instrument companies address the challenge of faster acquisition speeds over larger areas, and the medical community itself becomes more 'spectrophilic' and engaged in promoting the potential of spectropathology for the next generation.
